Market Cap 0.00
Revenue (ttm) 0.00
Net Income (ttm) 0.00
EPS (ttm) N/A
PE Ratio 0.00
Forward PE 11.55
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 4,263
Avg Vol 15,658
Day's Range N/A - N/A
Shares Out 0.00
Stochastic %K 83%
Beta N/A
Analysts Strong Sell
Price Target $41.20

Company Profile

Galderma Group AG operates as a dermatology company worldwide. The company delivers a science-based portfolio of brands and services for the dermatology market, including injectable aesthetics, dermatological skincare, and therapeutic dermatology. Its portfolio of flagship brands includes Actinica, Dysport/Azzalure, Alluzience, Restylane and Restylane Skinboosters, Sculptra, Cetaphil and Alastin, Soolantra, Epiduo and Epiduo Forte, Differin, Aklief, Epsolay, Twyneo, Oracea, Metvix, Mirvaso, Neml...

Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Phone: 41 58 455 85 92
Address:
Zählerweg 10, Zug, Switzerland
Latest News on GALDY
No data available.